Multiple immune and tissue cell populations via paracrine factors and cell–cell contact

The phrase "Multiple immune and tissue cell populations via paracrine factors and cell–cell contact" does not identify a specific molecular target, such as a protein or receptor, but rather describes a complex biological process of intercellular communication. This process involves the coordinated interaction of various immune cells (e.g., T-cells, B-cells, macrophages) and resident tissue cells (e.g., fibroblasts, endothelial cells) through the secretion of soluble mediators and direct physical contact (Alberts et al., Molecular Biology of the Cell, 2014). Such interactions are fundamental to maintaining tissue homeostasis and orchestrating immune responses, and their dysregulation is a hallmark of diseases like chronic inflammation, autoimmunity, and cancer (Galipeau & Sensébé, Cell Stem Cell, 2018). In the pharmaceutical industry, this terminology is frequently used to describe the broad, pleiotropic effects of advanced therapies, particularly mesenchymal stem cells (MSCs) and other cell-based products, which modulate the inflammatory environment through multiple simultaneous pathways rather than a single molecular switch. Because it represents a systemic physiological state or a mode of action involving numerous distinct molecules, it cannot be targeted by a single conventional drug and does not possess a unique molecular classification. Consequently, this entry is considered a descriptive physiological summary rather than a valid therapeutic target.

Other names

Cell-cell communicationParacrine signaling networkTissue microenvironment modulation

Not applicable as this entry describes a multicellular interaction process rather than a specific molecular target.